Biocon inks licensing pact with US-based Quark Pharma
To develop a range of siRNA based novel therapeutics
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SPARC receives US FDA response on Venlafaxine NDA
Venlafaxine extended-release tablets is an anti-depressant product
StelisBiopharma and Pieris Forge alliance for Novel Anticalin Therapeutics in ophthalmology
Collaboration foresees multiple first-in-class drug candidates
GSK to increase stake in its pharmaceuticals subsidiary in India
Intends to keep the company publicly-listed
Bridgepoint Development Capital acquires Quotient Clinical
Quotient Clinical has developed a platform which offers an integrated approach to formulation development, 'real-time' drug…
Past Issuess
Oct 16-31, 2014 Oct 1-15, 2014 Sept 16-30, 2014 Sept 1-15, 2014 Aug 16-31, 2014 Aug 1-15, 2014 July 16-31, 2014 July…
December 16-31, 2013
{source}<div data-configid="5690019/6022186" style="width: 600px; height: 402px;" class="issuuembed"></div><script…
Celebs call for change
Realising the phenomenal potential of celebrities to shape public opinion, the healthcare industry too has been wooing the stars…
’Flying Sikh’ Milkha Singh urges docs to ”put on their running shoes”
Builds up a strong case for physical fitness